DBV Technologies | Despesa De Juros Sobre A Dívida



Interest Expense On Debt Alterar Data
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amarin USD 0 8K 2024-06
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
DBV Technologies 784.71K 632.24K 2022-06
Halozyme Therapeutics USD 4.54M 16K 2024-12
Incyte USD 419K 355K 2024-12
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 42.11M 1.09M 2024-09
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12



DBV Technologies Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.